Insights
webinar
Casual Nexus – Episode Five: Saving Time in Hit-to-Lead Investigations
Presented by Mark Wolf, Ph.D., Section Head, Medicinal Chemistry - Curia Doug Kitchen, Ph.D., Section Head, CADD, Medicinal Chemistry - Curia Listen in as our experts discuss: The importance of a strong hit-to-lead program in drug d...
webinar
Casual Nexus – Episode Four: Strategies for HPAPI Containment to Enable Rapid Development and Production
Presented by Brian Haney, Ph.D., Director of Technical Operations, Curia Iain MacGilp, Ph.D., Director, GMP Production, Curia Listen in as our experts discuss: The basics of handling HPAPI's safely in GMP production settings The trad...
white paper
The Shift Toward US Pharmaceutical Manufacturing: Considerations in Attaining the Right Global Mix
The COVID-19 pandemic has brought the global interdependency of pharmaceutical supply chains into sharp focus, exposing weak links and re-igniting discussions around the value of reshoring production. The U.S. Food and Drug Administration (FDA) repor...
webinar
Casual Nexus – Episode Three: Sterile Drug Product Manufacturing During a Global Pandemic
Presenters: Ankit Agrawal, Senior Director, Commercial Strategy, Curia Anish Parikh, Vice President, Drug Product Sales & Marketing, Curia Listen in as our experts discuss: The shortage of sterile manufacturing capacity within CDMOs given...
webinar
Casual Nexus – Episode Two: T3P - A Versatile Peptide Coupling and Water Removal Reagent
Presenters: Peter Talbiersky, Ph.D., Manager of Fine Chemicals Sales, Curia Listen in as our experts discuss: The importance of a green and versatile condensation reagent Safe alternative for commonly used condensation reagents like dicyclohe...
webinar
Casual Nexus – Episode One: Formulation Development and Clinical Supply of Aseptic Liposomal
Presenters: Iain MacGilp, Ph.D., Director, GMP Production, Curia Amber McFarlane, Head of Formulation Development, Curia Listen in as our experts discuss: The importance of an integrated formulation development and clinical supply function th...
article
From Niche to Transformational: Using Biology for Chemistry in Pharmaceutical Development
Though synthetic biology may be regarded as a new or emerging field of science, the concept of applying biological systems to improve chemical synthesis goes back hundreds — arguably, thousands — of years. From the earliest fermentation processes...
article
Curia Signs on to Participate in Diversity Lab’s Mansfield Certification Program
As part of our deep commitment to diversity and inclusion in the workplace, Curia is very proud to be participating in the two-year Mansfield Rule: Legal Department Edition (MRLD) initiative.
webinar
Hit-to-Lead Optimization Strategy in Drug Discovery
In vitro biochemical assays make possible the high throughput screening (HTS) of large compound libraries. A successful HTS campaign is typically viewed as one that identifies large numbers of diverse chemical series hits as potential starting points...
article
Essentials of an Industry-Leading CDMO Partner for Highly Potent Projects
CDMOs that routinely handle highly potent compounds must raise the bar for containment, safety, and industrial hygiene. Diverse capabilities across chemistries, purification technologies, and analytical techniques — combined with the ability to sup...
article
Prefilled Syringes & Biologics: The Perfect Partnership of Medicine & Delivery
It is no coincidence that the booms in prefilled syringes (PFS) and biologic medicines are happening at the same time – the two are intrinsically linked. Innovative biologic medicines demand innovative delivery systems to match, and as the utility...
article
Overcome Common Pre-Filled Syringe Challenges through Partnership
The pre-filled syringe (PFS) space is one of the fastest growing pharma sectors, expected to be worth $9.7bn by 2025, or 9% CAGR. Compared with traditional vial delivery systems, PFS offers greater patient safety and lower manufacturing costs – bu...